Whalesbook
Eli Lilly has become the first pharmaceutical company to reach a $1 trillion market capitalization, marking a historic achievement. This success highlights the critical importance of corporate longevity, stable leadership, and relentless product innovation, offering vital lessons for long-term investors navigating a rapidly changing business world. The article contrasts this with declining company lifespans globally and compares R&D spending with Indian pharmaceutical firms.